Ed Rieflin

Ed Rieflin, Executive Vice President. Prior to Leviticus Cardio, Ed served for 19 years at Thoratec Corporation, St. Jude Medical and Abbott Laboratories as Senior Vice President - Heart Failure Sales. During his tenure the MCS and Heart Failure business revenue increased from $16M/year to over $500M/year, and their commercial team increased from 10 to 175 FTE's. Thoratec was acquired by St. Jude Medical in 2015 for $3.4B, and St. Jude Medical was acquired by Abbott in 2017 for $25B. Prior to that, Ed served in senior leadership roles at Lighthouse Medical, and North American Instrument Corporation (NAMIC). Ed graduated from Cornell University with a B.S. in Economics.